Shares of Abcam Plc (LON:ABC) have been given a consensus recommendation of “Hold” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is GBX 866 ($11.02).

Several research firms have issued reports on ABC. Numis Securities Ltd raised Abcam Plc to an “add” rating and set a GBX 912 ($11.60) price target on the stock in a report on Tuesday, April 4th. Berenberg Bank began coverage on Abcam Plc in a report on Tuesday. They issued a “buy” rating and a GBX 1,100 ($13.99) price target on the stock. Peel Hunt reaffirmed a “hold” rating and issued a GBX 750 ($9.54) price target on shares of Abcam Plc in a report on Monday, March 6th. Stifel Nicolaus reaffirmed a “hold” rating and issued a GBX 890 ($11.32) price target on shares of Abcam Plc in a report on Tuesday, May 2nd. Finally, J P Morgan Chase & Co reaffirmed a “neutral” rating and issued a GBX 678 ($8.62) price target on shares of Abcam Plc in a report on Tuesday, March 7th.

In other news, insider Mara G. Aspinall bought 2,700 shares of the business’s stock in a transaction on Monday, June 5th. The shares were bought at an average cost of GBX 979 ($12.45) per share, with a total value of £26,433 ($33,621.22).

Abcam Plc (ABC) opened at 985.50 on Tuesday. The stock’s market capitalization is GBX 1.99 billion. Abcam Plc has a 1-year low of GBX 628.00 and a 1-year high of GBX 1,015.00. The company has a 50-day moving average price of GBX 964.59 and a 200 day moving average price of GBX 863.28.

TRADEMARK VIOLATION NOTICE: This story was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at

About Abcam Plc

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Analyst Recommendations for Abcam Plc (LON:ABC)

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with's FREE daily email newsletter.